Shanghai Allist Pharmaceuticals Co., Ltd.

SHSE:688578 Stock Report

Market Cap: CN¥43.3b

Shanghai Allist Pharmaceuticals Management

Management criteria checks 2/4

Shanghai Allist Pharmaceuticals' CEO is Jinhao Du, appointed in Sep 2022, has a tenure of 3.67 years. directly owns 2.4% of the company’s shares, worth CN¥1.04B. The average tenure of the management team and the board of directors is 5.5 years and 3.1 years respectively.

Key information

Jinhao Du

Chief executive officer

CN¥5.0m

Total compensation

CEO salary percentagen/a
CEO tenure3.7yrs
CEO ownership2.4%
Management average tenure5.5yrs
Board average tenure3.1yrs

Recent management updates

Recent updates

CEO

Jinhao Du (71 yo)

3.7yrs
Tenure
CN¥4,951,100
Compensation

Mr. Jinhao Du serves as Chairman of the Board at Shanghai Allist Pharmaceuticals Co., Ltd. since November 28, 2019 and serves as its General Manager since September 14, 2022.

Leadership Team

NamePositionTenureCompensationOwnership
Jinhao Du
Chairman of the Board & GM3.7yrsCN¥4.95m2.4%
CN¥ 1.0b
Jie Hu
Vice Chairman & Deputy GM6.2yrsCN¥3.04mno data
Lin Wang
Financial Director3.1yrsCN¥2.43mno data
Chen Huang
Marketing Manager3.1yrsCN¥4.04mno data
Feng Xu
Deputy GM & Director6.5yrsCN¥2.85mno data
Huafeng Shan
Chief Quality Officer4.9yrsCN¥1.56mno data
Shuo Li
Board Secretary6.2yrsCN¥1.01mno data
Quan Gan
Accounting Supervisorno datano datano data
Huayong Zhou
Deputy Director of R&D7.9yrsno datano data
5.5yrs
Average Tenure
50yo
Average Age

Experienced Management: 688578's management team is seasoned and experienced (5.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Jinhao Du
Chairman of the Board & GM6.5yrsCN¥4.95m2.4%
CN¥ 1.0b
Jie Hu
Vice Chairman & Deputy GM6.2yrsCN¥3.04mno data
Feng Xu
Deputy GM & Director3.1yrsCN¥2.85mno data
Zhengbin Yao
Member of Scientific Advisory Boardno datano datano data
Jianzhu Chen
Member of Scientific Advisory Boardno datano datano data
Yong Ben
Member of Scientific Advisory Boardno datano datano data
Cong Xu
Director1.5yrsno datano data
Chafen Zhu
Independent Directorless than a yearno datano data
Ju Qi
Director6.5yrsCN¥759.10kno data
Shengming Chu
Employee Representative Directorless than a yearno datano data
Lijun Wang
Employee Representative Supervisor3.1yrsno datano data
Hanjie Li
Independent Directorless than a yearno datano data
3.1yrs
Average Tenure
51yo
Average Age

Experienced Board: 688578's board of directors are considered experienced (3.1 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/08 09:01
End of Day Share Price 2026/05/08 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Shanghai Allist Pharmaceuticals Co., Ltd. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pei ChengChina Galaxy Securities Co., Ltd.
Wenxin YuHaitong International Research Limited
Yuan Yuan SunIndustrial Securities Co. Ltd.